摘要
目的:建立裸鼠皮下人B-淋巴细胞移植瘤模型,研究抗CD3/CD20。微型双功能抗体在裸鼠体内的分布。方法:采用亲和层析分离纯化本室构建的抗 CD3/抗 CD20微型双功能抗体可溶性表达产物,并用SDS-PAGE、Western blot、分子排阻层析和 FACS鉴定纯化产物;采用5周龄左右的雌性 BALB/c-nu,经4Gy照射、皮下接种 Raji细胞建立裸鼠皮下人B-淋巴细胞移植瘤模型,并于眼底静脉丛注射125I标记的抗CD3/抗CD20微型双功能抗体,测定各组织中125I的分布。结果:雌性BALB/c-nu经照射、皮下接种1×10~7~3×10~7Raji细胞/只,6~14天均开始出现移植瘤,移植瘤细胞膜表面标记与 Raji相同,且在24小时时肿瘤部位125 I的分布明显低于心、肝、肾、脾,其比值分别为0.08、0.19、0.06和0.51,而 72小时时肿瘤部位125I的分布则高于心、肝、肾、脾,其比值分别为 2.32、9.46、8.24和9.50。结论:抗CD3/抗CD20微型双功能抗体能在裸鼠皮下人B-淋巴细胞移植瘤部位富集,是一个有望用于B细胞恶性肿瘤临床治疗的双特异性抗体。
Objective: To study the development of human Raji tumor cell nude mouse xenograft model in order to research distribution of Anti-CD3/CD20 Diabody (Diabody) in nude mouse. Methods: The Diabody was purified by affinity chromatography and analysed by both the detection of Western blot, size exclusion chromatography and FACS. Human Raji cells were inoc- ulated into nude mouse subcutaneously, 3 days after irradiation with 4-Gy dose, the 125I-Diabody, K was injected when tumor volume reached about 100mm3, Results: All nude mice grafted with Raji cell line grown tumor, the rate of tumor growing was 100 percent. Both the tumor cells in vivo and Raji cells produced same antigens. Distribution of 72h 125I-Diabody in tumor was high- er than in heart, liver, kidney and spleen and the ratio of them were 2.32, 9.46, 8.24 land 9.50 respectively. Conclusion: The anti-CD3/CD20 Diabody is able to be concentrated in B cell tumor in nude mouse xenograft model and is porved as a potent, anti-tumor agent for clinical therapy of human B cell lymphomas.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2001年第5期375-379,共5页
Chinese Journal of Clinical Oncology
基金
国家863计划资助(102-09-03-03)